ALB and diabetes mellitus: Approximately 40% or less annual uACR testing for the US diabetes population was shown in other national datasets from the 5% Medicare sample,27 clinical laboratories,11 and health systems,12 supporting the need for interventions and quality improvement measures to increase targeted albuminuria testing.10, 11, 12,28 In addition, further analysis of the subpopulation without a uACR test found that 17%-20% had a quantitative urine albumin test, whereas 7%-8% had a urine creatinine test.